Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01581671 · ClinicalTrials.gov registry record

Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography

A clinical trial of Coronary Artery Disease, sponsored by Mayo Clinic.

Completed
Registry status
201
Enrollment target
1
Study location

NCT01581671 is a study of Coronary Artery Disease that has completed, run by Mayo Clinic. The registered enrollment target is 201 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01581671, a study of Coronary Artery Disease, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
201 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the non-invasive, Peripheral Arterial Tonometry (PAT) testing as another way of predicting potential coronary artery blockages in the heart.

Conditions Studied

Study Locations (1)

Minnesota

  • Mayo Clinic - Rochester

Trial Details

FieldValue
Enrollment Target 201 participants
Start Date 2010-09
Est. Completion 2014-06

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT01581671

The ClinicalTrials.gov registry entry for NCT01581671 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 201 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (84% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 0 interventions.

NCT01581671 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT01581671 about?

NCT01581671 is a clinical study titled "Non-Invasive EndoPAT Increases Diagnostic Yield of CAD by Coronary Angiography". The purpose of this study is to assess the non-invasive, Peripheral Arterial Tonometry (PAT) testing as another way of predicting potential coronary artery blockages in the heart.

What is the current status of trial NCT01581671?

This trial is currently completed. The enrollment target is 201 participants. The study started on 2010-09. Estimated completion is 2014-06.

What conditions does trial NCT01581671 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

Who is sponsoring clinical trial NCT01581671?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01581671 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.